Innovative
Therapeutics for
Better Health

Because Life
Shouldn't Have to
Wait for Migraines

Our Lead Product Candidate

STS101

Dihydroergotamine (DHE) Nasal Powder

Learn More

Clinical Trials

SUMMIT™ Trial

Currently Recruiting

Learn More

Clinical Trials

ASCEND™ Trial

Ongoing

Learn More

Press Releases

Sep 08, 2021

Satsuma Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Read More

Aug 10, 2021

Satsuma Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Business Highlights

Read More